# Heparin for Pregnant Women With Thrombophilia

> **NCT01019655** · PHASE3 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 300 (estimated)

## Conditions studied

- Pregnancy and Thrombophilia

## Interventions

- **DRUG:** Nadroparin calcium

## Key facts

- **NCT ID:** NCT01019655
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2009-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01019655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01019655, "Heparin for Pregnant Women With Thrombophilia". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01019655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*